RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.

The Essential FDA/PDR Indications and Warnings For Opioid Prescribing

The Physicians’ Desk Reference should no longer be viewed as interesting bits of information generated by a pharmaceutical company to sell a product. Rather, the indications and warnings are a collaborative effort by the manufacturer and FDA and must be known and followed by prescribers of opioids.
Page 3 of 3

The indications and warnings given in the FDA/PDR appear reasonable and appropriate given the epidemic of opioid diversion and overdose deaths that has occurred because of nonindication prescribing.2,3 If a practitioner wishes to prescribe any long-acting opioid, it is highly recommend that the indications for transdermal fentanyl be used as the model and guideline.

Last updated on: September 20, 2011
SHOW MAIN MENU
SHOW SUB MENU